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Abstract
Background: Changes in bacterial populations termed ‘‘dysbiosis’’ are thought central to ulcerative colitis (UC)
pathogenesis. In particular, the possibility that novel Helicobacter organisms play a role in human UC has been debated
but not comprehensively investigated. The aim of this study was to develop a molecular approach to investigate the
presence of Helicobacter organisms in adults with and without UC.
Methodology/Principal Findings: A dual molecular approach to detect Helicobacter was developed. Oligonucleotide
probes against the genus Helicobacter were designed and optimised alongside a validation of published H. pylori probes. A
comprehensive evaluation of Helicobacter genus and H. pylori PCR primers was also undertaken. The combined approach
was then assessed in a range of gastrointestinal samples prior to assessment of a UC cohort. Archival colonic samples were
available from 106 individuals for FISH analysis (57 with UC and 49 non-IBD controls). A further 118 individuals were
collected prospectively for dual FISH and PCR analysis (86 UC and 32 non-IBD controls). An additional 27 non-IBD controls
were available for PCR analysis. All Helicobacter PCR-positive samples were sequenced. The association between Helicobacter
and each study group was statistically analysed using the Pearson Chi Squared 2 tailed test. Helicobacter genus PCR
positivity was significantly higher in UC than controls (32 of 77 versus 11 of 59, p=0.004). Sequence analysis indicated
enterohepatic Helicobacter species prevalence was significantly higher in the UC group compared to the control group (30
of 77 versus 2 of 59, p,0.0001). PCR and FISH results were concordant in 74 (67.9%) of subjects. The majority of discordant
results were attributable to a higher positivity rate with FISH than PCR.
Conclusions/Significance: Helicobacter organisms warrant consideration as potential pathogenic entities in UC. Isolation of
these organisms from colonic tissue is needed to enable interrogation of pathogenicity against established criteria.
Citation: Thomson JM, Hansen R, Berry SH, Hope ME, Murray GI, et al. (2011) Enterohepatic Helicobacter in Ulcerative Colitis: Potential Pathogenic Entities? PLoS
ONE 6(2): e17184. doi:10.1371/journal.pone.0017184
Editor: Tanya Parish, Queen Mary University of London, United Kingdom
Received September 2, 2010; Accepted January 24, 2011; Published February 23, 2011
Copyright:  2011 Thomson et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This study was funded by the Broad Medical Research Program (Grant number IBD-0178). JMT was supported by grants from the GI Research Unit,
Aberdeen Royal Infirmary; RH was supported by a Clinical Academic Training Fellowship, from the Chief Scientist Office (CAF/08/01). The funders had no role in
study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: g.l.hold@abdn.ac.uk
Introduction
Ulcerative colitis (UC) is a chronic condition of the human
colon which affects the superficial mucosal layer from the rectum
and extending proximally for variable distances [1]. This variable
phenotype remains a puzzle, as does our difficulty in achieving
long-term cure with current treatments. Recent developments in
genetics have greatly improved our understanding of the
inflammatory bowel diseases (Crohn’s disease and UC), resulting
in a renewed interest in the interplay between host immunology
and bacteria at the mucosal surface; however genetic elements
appear to be more important in Crohn’s disease (CD) than UC.
The possibility of infection as a trigger event for, or indeed as the
cause of, inflammatory bowel disease (IBD) has long been debated
with various organisms being suggested as pathogens. None of
these organisms have been conclusively proven as causative agents.
Studies examining the diversity of bacteria in IBD have shown
increased cell counts of bacteria and reduced bacterial diversity.
Changes in bacterial populations to the detriment of the host have
been termed ‘‘dysbiosis’’ and this change is thought central to IBD
pathogenesis. IBD onset following infectious episodes is well
described and one possibility is that gastrointestinal infection may
facilitate dysbiosis and ultimately IBD. Whether acute self-limiting
infection is sufficient as a single entity, or whether chronic
infection with as yet unknown agents is required to drive the
chronicity of disease is unknown. UC is a stronger candidate than
CD for a purely infectious aetiology because of the weaker genetic
association, continuity of disease distribution and the relative
limitation of disease to superficial tissue. It is likely however that a
combination of host (genetic) susceptibility, a trigger event (which
may be infectious) and the progression to dysbiosis are all likely
required for the development of IBD.
The discovery that Helicobacter pylori was the causative agent
underpinning gastric and duodenal ulceration and ultimately
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and resulted in a Nobel prize for Robin Warren and Barry
Marshall. The tantalising possibility that a similar agent is
responsible for IBD warrants consideration and exploration [2].
The family Helicobacteraceae contains the genera Helicobacter and
Wolinella. The Helicobacter genus can be split into two groups,
gastric Helicobacter, describing those that preferentially colonise the
stomach, and enterohepatic Helicobacter, which preferentially
colonise the intestinal or hepatobilliary system (Table 1). Entero-
hepatic Helicobacter organisms have been cultured from both
Cotton-top tamarin monkeys (Saguinus oedipus) and rhesus monkeys
(Macaca mulatta) with colitic disease (Helicobacter sp. Flexispira taxon
10, Helicobacter macacae and Helicobacter sp. Rhesus monkey 2), whilst
Helicobacter hepaticus and Helicobacter bilis have been shown to be
capable of causing IBD-like disease in immunodeficient rodent
models [3–5]. Thus animal models demonstrating that infection
with Helicobacter spp. on a background of host immunodeficiency
can lead to colitis, and that ‘‘auto-immune’’ type reactions to
commensal bacteria can be initiated by such organisms, would
suggest the possibility of parallel mechanisms in humans resulting
in IBD.
Various groups have examined human IBD for the presence of
Helicobacter spp., from the negative studies of Bell and Grehan
[6,7], through to studies by Bohr, Zhang and Laharie which have
successfully demonstrated PCR evidence of non-pylori Helicobacter
(npH) in both IBD and controls [8–10]. The methodologies used,
the variable rates of positivity reported between groups, and the
small study numbers included in some, mean discussions at
Helicobacter species level have been limited. Unfortunately, no-one
has successfully cultured non-pylori Helicobacter organisms from IBD
tissue (although 7 enterohepatic Helicobacter spp. have been
cultured from the gastrointestinal tract of humans with diarrhoea
or systemic disease [2]). The difficulties in isolating and culturing
non-pylori Helicobacter from human colonic tissue highlight the
importance of molecular approaches as viable alternatives to
facilitate the study of the role of Helicobacter spp. in extra-gastric
diseases. However, it is vital that these molecular methods are
suitably sensitive, specific and applicable to a diverse range of
samples. The purpose of the present study was to design a
combined molecular approach to identify Helicobacteraceae organ-
isms within a variety of gastrointestinal sample types. Our specific
aim was to examine colonic tissue from IBD patients to assess the
prevalence of Helicobacteraceae organisms against tissue from
controls largely undergoing colorectal cancer screening. We
elected to analyse UC cases rather than CD cases for the reasons
outlined above regarding UC as a stronger candidate for an
infectious aetiology.
Methods
Ethics Statement
Ethical approval for the archival specimen analysis and the
biopsy study was granted by North of Scotland Research Ethics
Service and written informed consent was obtained from all
subjects in the biopsy study.
Development of a Combined Molecular Approach for the
Detection of Helicobacteraceae Organisms
Development of PCR Methodology. A bacterial reference
panel was used to screen a series of primer combinations. The
bacterial strains used in this study included: Helicobacter bilis
(ATCC 51630), H. canadensis (ATCC 700968), H. canis (ATCC
51402), H. cholecystus (ATCC 700242), H. cinaedi (CCUG 18818),
H. felis (ATCC 49179), H. hepaticus (ATCC 51449), H. pullorum
(NCTC 12824), H. pylori (ATCC 700392), Pseudomonas fluorescens
(clinical isolate), Listeria monocytogenes (clinical isolate), Aeromonas
caviae (clinical isolate), Aeromonas sobria (clinical isolate), Campylobacter
jejuni (clinical isolate), Proteus mirabilis (NCTC 3177), Enterobacter
aerogenes (NCIMB 10102), Yersinia enterocolitica (NCIMB 2124),
Bifidobacterium longum (NCIMB 8809), Bifidobacterium infantis (DSM
20088), Eubacterium rectale (NCIMB 14373), Roseburia intestinalis
(DSM 14610), Bacteroides vulgatus (DSM 1447), Bacteroides
thetaiotaomicron (NCTC 10582), Eubacterium hallii (DSM 17630),
Enterococcus faecalis (NCIMB 13280), Pseudomonas aeruginosa (NCIMB
8626), Enterobacter cloacae (NCIMB 8556), Proteus vulgaris (NCTC
4175), Salmonella enteritidis (NCTC 12694), Salmonella poona (NCTC
4840), Salmonella typhimurium (NCIMB 13284), Escherichia coli
(NCIMB 12210), Shigella sonnei (ATCC 25931), Staphylococcus
epidermidis (NCIMB 8853), Bacillus subtilis (NCIB 8054), Bacillus
cereus (ATCC 10876), Klebsiella pneumoniae (NCIMB 13281),
Staphylococcus aureus (NCIMB 12702), Streptococcus gordonii (ATCC
35105), Faecalibacterium prausnitzii strain A2-165 (DSM 17677),
Megasphaera elsdenii (ATCC 25940), Bifidobacterium adolescentis isolate
L2-32, Lactococcus lactis strain MG1363, Enterococcus faecalis strain
JH2-2, Ruminococcus albus strain SY3, Ruminococcus flavefaciens strain
17, Eubacterium cylindroides strain T2-87, Coprococcus spp L2-50,
Methanobrevibacter smithii ATCC 35061, Acinetobacter baumanii,
Lactobacillus acidophilus (ATCC 43561) and Streptococcus bovis strain
Z6. Aerobic and microaerobic strains were grown at 37uCo n
Columbia agar with 10% horse blood. Anaerobic strains were
Table 1. Classification of named Helicobacter spp. as Gastric
or Enterohepatic.
Gastric Enterohepatic
H. acinonychis H. anseris
H. aurati *H. bilis
H. bizzozeroni H. brantae
H. cetoreum *H. canis
H. felis *H. canadensis
H. mustelae H. cholecystus
*H. pylori *H. cinaedi
H. salomonis H. equorum
H. suis *H. fennelliae
H. bovis (candidate species) H. ganmani
H. suncus (candidate species) H. hepaticus
H. cyanogastricus H. mastomyrinus
H. marmotae
H. mesocricetorum
H. magdeburgensis
H. muridarum
H. pametenis
*H. pullorum
H. rodentium
H. suncus
H. trogontum
H. typhlonicus
H. westmeadii
*H. winghamensis
*Isolated from humans.
doi:10.1371/journal.pone.0017184.t001
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Dickinson, Oxford, UK). All strains were used in fluorescent in-situ
hybrisation (FISH) and PCR optimisation studies.
Initial assessment used a universal 16S bacterial PCR described
previously [12]. To allow identification of the family Helicobacter-
aceae (genera Helicobacter and Wolinella), 8 Helicobacteraceae PCR
primer pairs were assessed. The nested PCR combination of C05
and C97 [13] followed by a reverse complement of primer C98
[13] and1067r [14] was selected as it yielded a final product of
suitable length (,400 bp) for sequence analysis. For H. pylori
specific PCR, numerous H. pylori specific primer sets targeting the
16S rRNA gene were assessed with the most successful pairing
being identified as 27f (59-AGAGTTTGATCMTGGCTCAG-39)
[15] and HPY (59-CTGGAGAGACTAAGCCCTCC-39) [16].
Both PCRs utilised the following conditions: denaturation at 94uC
for 5 min, followed by 35 cycles of 94uC for 1 min, 66uC for
1 min, 72uC for 2 min. Final extension 72uC for 10 min. To
determine the sensitivity of the genus PCR, decreasing amounts of
H. pylori and H. hepaticus-derived DNA were spiked into faecal
samples which were previously analysed by FISH and PCR and
found to be negative for Helicobacteraceae. Dilutions ranged from
500 pg to 0.05 pg of Helicobacter DNA with the detection level of
0.5 pg Helicobacter DNA (representing approximately 30 bacteria)
consistently being achieved.
Development of FISH Methodology. Five broad-specificity
probes were designed to target the small subunit rRNA of the
family Helicobacteraceae (Table 2). The new probes were designed
with the Primrose software package [17], checked against the
Ribosomal Database Project (RDP) and EMBL databases, and
were named according to the nomenclature suggested by the
Oligonucleotide Probe Database (OPD) [18]. One of the designed
Helicobacteraceae probe sequences S-G-Hel-1047-a-A-21 had been
previously described as a Helicobacter genus specific PCR primer
[14] but to our knowledge it has not been used as a probe. Of note,
in-silico analysis indicated that this probe detects several bacteria of
the genera Sulfurimonas (17 of 21), Sulfurovum (9 of 42) and Wolinella
(4 of 5). The specificity of the 5 newly designed Helicobacteraceae
probes along with four previously published H. pylori specific
probes (Table 2) was tested by whole-cell in situ hybridization
against a panel of 60 reference strains derived from the human and
animal gastrointestinal tract (see above) including a panel of 9
Helicobacter type strains [19]. As a positive control for the presence
of bacteria, the bacterium-specific probe S-D-Bact-0338-a-A-18
(termed Eub338) was used [20]. Following assessment of the
various Helicobacteraceae probes, it was identified that the
Helicobacteraceae probe S-G-Hel-1047-a-A-21 and the H. pylori
specific probe Hp16S2 hybridized only to the respective target
organisms but not to any of the other organisms tested. Both the
Eub338 and Hp16S2 hybridised at 50uC and could be co-
hybridised using discriminating fluorescent labels (Rhodamine red
and Oregon green 488 respectively). S-G-Hel-1047-a-A-21
hybridised at 52uC.
Validation of Molecular Methods (PCR/FISH) for the
Detection of Helicobacteraceae Organisms. In order to
calculate the sensitivity and specificity of the dual molecular
approach 100 gastric samples were selected on the basis of H. pylori
status (50 positive and 50 negative). H. pylori status had been
confirmed previously by CLO test and histology; however this was
blinded to researchers until after molecular assessment. FISH was
performed on archival paraffin tissue sections and PCR was
performed on DNA extracted from fresh biopsies.
Biopsy blocks were cut to a thickness of 4 mm using a Leica
RM2125RT rotary microtome with sections cut per block, and
mounted on ChemMate capillary gap slides, 75 mm, (DakoCyto-
mation, Cambridgeshire, UK). Following microtome sectioning
and mounting of tissue, slides were dried vertically at room
temperature and incubated overnight at 37uC to ensure that the
tissue was adhered to the slide. Slides were then arranged by
patient and block number and sections 1, 3 and 5 were used for
assessing the presence of H. pylori coupled with the universal
bacterial probe. Sections 2, 4 and 6 were used for assessing the
presence of all Helicobacteraceae. Biopsy sections were deparaffinised
Table 2. Probes used for fluorescent in-situ hybridisation (FISH).
Probe 16S rDNA position
ab Probe sequence
c Fluorophore Reference
Universal
Eub A 338–355
a 59 - GCT GCC TCC CGT AGG AGT - 39 Rhodamine red [20]
Eub B 338–355
a 59 - GCT GCC ACC CGT AGG TGT - 39 Rhodamine red [40]
Eub C 338–355
a 59 - GCA GCC ACC CGT AGG TGT - 39 Rhodamine red [40]
Helicobacteraceae family specific
Hgen1 218–235
b 59- ARC TGA TAG GAC ATA GRC - 39
c Cy3 This study
Hgen2 666–683
b 59 - TGA GTA TTC YTC TTG ATM - 39
c Oregon green 488 This study
Hgen3 657–674
b 59 - CTC TTG ATC TCT ACG GAT - 39 Oregon green 488 This study
Hgen4 630–647
b 59 - ACA CCA AGA ATT CCA CCT - 39 Oregon green 488 This study
Hgen5 1047–1067
b 59 - GCC GTG CAG CAC CTG TTT TCA - 39 Oregon green 488 This study
Helicobacter pylori specific
Hpy-1 547–567
b 59- CACACCTGACTGACTATCCCG - 39 Cy3 [21]
HP2 796–815
b 59- CTG GAG AGA CTA AGC CCT CC - 39 Oregon green 488 [16]
Hp16S-1 163–185
b 59- GGAGTATCTGGTATTAATCATCG - 39 Oregon green 488 [41]
Hp16S-2 206–227
b 59- GGACATAGGCTGATCTCTTAGC -39 Oregon green 488 [41]
aIndicates E. coli numbering.
bIndicates H. pylori numbering to strain 26695 (ATCC 700392).
cIndicates degeneracy of nucleotides according to IUPAC see http://www.chem.qmul.ac.uk/iubmb/misc/naseq.html.
doi:10.1371/journal.pone.0017184.t002
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deparaffinised tissue sections, 50 ml of hybridisation buffer was
added and coverslips were used to minimise evaporation.
Hybridisation was performed for 16 hours for all tissue sections
and Vectashield Hardmount (Vector Laboratories, Peterborough,
UK) was used.
DNA extraction of mucosal biopsies was performed using the
commercially available Qiagen QIAamp Mini kit (Qiagen
Crawley UK) with the following amendments. Biopsy samples
were kept frozen until the addition of ATL buffer before allowing
biopsies to equilibrate to room temperature, an additional 10 mlo f
Proteinase K was added for an initial lysis period of 18 hours to
ensure complete lysis of the biopsy material prior to DNA
extraction. PCR was performed as described above with biopsy
DNA initially subjected to universal bacterial PCR [12] to confirm
the suitability of the DNA for further analysis.
One hundred infectious diarrhoea samples were also collected
for inclusion in the validation cohort. Samples were obtained from
the Department of Medical Microbiology (Aberdeen Royal
Infirmary, Aberdeen) and DNA was extracted using the Nucleon
phytopure DNA extraction kit. PCR was performed as described
above with faecal DNA initially subjected to universal bacterial
PCR [12] to confirm the suitability of the DNA for further
analysis.
Assessment of Helicobacteraceae Prevalence in Human
Colonic Tissue Using the Combined Molecular Approach
Archival colonic tissue specimens. Paraffin embedded
colonic specimens from a total of 106 patients were obtained
from the Department of Pathology (Aberdeen Royal Infirmary).
Fifty-seven ulcerative colitis (UC) patients and forty-nine healthy
controls (HC) were included. All UC patients were assessed during
active disease and analysis was performed on all available colonic
sites that were biopsied at the time of colonoscopy. The HC
subjects comprised individuals who had undergone a colonoscopy
in which colonic tissue was macroscopically normal, and
subsequently confirmed as microscopically normal by histology.
This cohort was examined exclusively by the FISH method
outlined above. This sample cohort was not amenable to PCR
methodologies.
Fresh colonic biopsy specimens. A total of 145 individuals
were recruited for the prospective fresh biopsy study, 86 formed
the ulcerative colitis (UC) cohort and were analysed alongside a
cohort of 59 healthy controls (HC). Of the UC cohort 9 individuals
were excluded, 3 could not undergo colonoscopy for clinical
reasons and 6 had an alternative final diagnosis. The HC cohort
comprised two groups. The first group (N=32) were recruited
specifically for this study and had biopsies collected for both FISH
and PCR studies (as outlined above). The second group (N=27)
had been recruited previously and all 27 had biopsies collected
from normal colon whilst undergoing polypectomy.
Biopsies were collected during colonoscopy using standard
endoscopic forceps (Boston Scientific Nanterre Cedex France).
The colonic mucosa was rinsed with sterile water via the
colonoscope to remove residual faecal material. Biopsies were
immediately snap frozen in liquid nitrogen and then transferred to
a 280uC freezer until used for DNA analysis. Additional biopsies
were also sent for histopathology assessment and FISH analysis.
Biopsies were only collected for PCR based studies and so FISH
analysis was not studied in this cohort. Therefore mucosal biopsies
were obtained from 136 individuals, 77 with a clinical and
histological diagnosis of UC (55 established disease – three had
antibiotic therapy in the 6 months prior to study recruitment, 22
de-novo) and 59 healthy controls. The entire UC group had biopsies
collected for both fluorescent in-situ hybridisation (FISH) and PCR
studies. Samples that generated positive PCR results with
Helicobacteraceae or H. pylori PCR primers were sequenced to
confirm identity. Based on sequence analysis results, samples that
were suspected of containing multiple Helicobacter sequences were
cloned [12] and 5 clones per sample were sent for sequence
analysis (400 bp).
Ethical approval for the archival specimen analysis and the
biopsy study was granted by North East of Scotland Research
Ethics Service and written informed consent was obtained from all
subjects in the biopsy study.
Statistical analysis
Statistical analysis with the Pearson Chi Squared 2 tailed test,
was performed using SPSS statistics software version 17.0.1
(December 1 2008).
Results
Validation of Molecular Methods (PCR/FISH) for the
Detection of Helicobacteraceae Organisms
Fifty of the gastric biopsy samples demonstrated FISH positivity
using both Helicobacteraceae and H. pylori specific probes along with
the universal Eub338 probe. The same 50 samples testedpositive by
PCR for Helicobacteraceae, H. pylori specific and universal bacterial
primer sets with a subset of results (N=10) subjected to sequence
analysis which confirmed the presence of H. pylori (sequence
identities .99%). The molecular results were 100% concordant
with the findings of clinical investigation indicating that the
combined approach had a high diagnostic sensitivity and specificity.
The combined molecular approach was then applied to 100
infectious diarrhoea samples. All infectious diarrhoea samples
showed positivity with the universal bacterial FISH probe
(Eub338) and the universal bacterial PCR. One diarrhoea sample
was positive for Helicobacter by FISH and both Helicobacteraceae and
H. pylori specific PCR with sequencing confirming the presence of
H. pylori. As non-pylori Helicobacter organisms have been isolated
from diarrheal samples previously, we performed a series of
spiking experiments to confirm that the diarrheal samples were not
inhibiting PCR amplification. Ten samples which were negative
for Helicobacteraceae by both FISH and PCR were spiked with H.
pylori DNA (500 pg to 0.5 pg) prior to PCR amplification. All
spiked samples yielded positive PCR and subsequent sequencing
results (.99% sequence similarity, over 360 bp, to the spiked H.
pylori 16S rDNA gene sequence) confirming that if present these
organisms would have been detected.
Helicobacteraceae Prevalence in Human Colonic Tissue
Archival study. The UC archival cohort (n=57, 44% Male)
had a median age of 40 (range 15–82) at the time of colonoscopy
and were classified as extensive (40%), left sided (37%) and
proctitis (23%) according to the Montreal criteria [22]. A total of
284 biopsies were analysed with 46% of subjects having biopsies
from inflamed and un-involved mucosa available (E1 n=8, E2
n=9, E3 n=9) and the remainder having biopsies only from
inflamed mucosa. The HC archival cohort (n=49, 35% Male) had
a median age of 42 (range 14–80) at the time of colonoscopy. A
total of 127 biopsies were processed in triplicate to assess the
presence of Helicobacteraceae from the available pathology blocks of
the right and left colon including rectum. Subjects were considered
to be positive if appropriate fluorescent organisms were observed
in at least 1 slide. All fluorescent in-situ hybridisations were assessed
alongside H. pylori positive gastric biopsy reference slides and a
selection of Helicobacter reference strains. All of the 106 subjects had
Enterohepatic Helicobacter Strains in UC
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subjects positive for Helicobacteraceae, 29 were from the UC cohort
and 26 were from the HC cohort. In both groups there was no
statistically significant correlation with gender or age of the
subjects and in the UC cohort the extent of disease did not
correlate with the rate of positivity either as detailed in Table 3.
Interestingly there was a statistically significant difference in the
presence of Helicobacter pylori with 13 of the Helicobacteraceae positive
subjects from the HC cohort also having a positive result for
Helicobacter pylori compared with only 3 of the UC cohort
(p=0.002). Assuming that these Helicobacter pylori positive results
represent transported gastric Helicobacter pylori we consequently
removed these from the Helicobacteraceae positive results, thus
creating a new category of non-pylori Helicobacter positive
organisms. By this approach there was also a statistically
significant difference in the presence of non-pylori Helicobacter
organisms between the UC and HC cohorts (p=0.04). There was
no correlation with age, gender or severity of disease as detailed in
Table 3. Because of limitations of the archival FISH technique it
was not possible to ascertain if the H. pylori organisms were entirely
responsible for the genus positivity or if the H. pylori were
cohabiting with other non-pylori Helicobacter. Indeed, it was also not
possible to ascertain if more than one Helicobacteraceae species was
present within a sample. Attempts were made to extract microbial
DNA from the archival tissue but these were unsuccessful and
therefore a prospectively collected cohort was established with
samples taken for PCR based analyses and FISH analysis.
Prospective study. The prospective UC cohort (n=77, 46%
Male) had a median age of 42 (range 16–84) at the time of index
colonoscopy and were classified as extensive (25%), left sided
(62%), proctitis (13.0%). A total of 137 biopsy sites were analysed.
Twenty one (27%) subjects had a single site analysed, all of which
represented inflamed mucosa and 56 (73%) had more than one
biopsy site assessed, of which 42 both had inflamed and
uninvolved mucosa. The prospective HC cohort (n=59, 59%
Male) had a median age of 63 (range 30–75) at the time of index
colonoscopy. There was a statistically significant median age
difference between the UC cohort and the control groups (Mann
Whitney U test p,0.001). A single biopsy site (n=59) was
analysed from each control subject. All 136 subjects (77 UC and
59 controls) had colonic biopsies available for PCR analysis and all
were positive for universal bacterial PCR indicating the presence
of bacterial DNA within all samples. Of the 136 subjects, 43 (32%)
were PCR positive for Helicobacteraceae and 3 (2%) were PCR
positive for both Helicobacter pylori and Helicobacter genus (Table 4).
Subsequent sequence analysis of the Helicobacteraceae PCR products
confirmed the presence of only Helicobacter pylori in these 3 samples.
Thus 40 subjects were PCR positive for Helicobacteraceae but not H.
pylori. Sequence analysis revealed a further 4 subjects (3 controls
and 1 UC) with only Helicobacter pylori identified.
In the remaining 36 subjects sequence analysis identified the
presence of a further 8 Helicobacter species and a Wollinella
succinogenes with 6 subjects having more than one species identified
(Table 5). Of these subjects, 3 had multiple Helicobacter species
present within the same biopsy sample and 3 had different
Helicobacter species spread between the samples analysed (Table
S1). Helicobacter pylori were not found to co-exist with any other
Helicobacteraceae species. The species identified and the number of
samples they were identified in is detailed in Table S1.
Helicobacteraceae PCR positivity was significantly higher in UC
than controls 32 of 77 (42%) versus 11 of 59 (19%), p=0.004). By
analysing the sequences obtained and including only those
Helicobacter species classified as ‘‘enterohepatic,’’ the prevalence
was 29 of 77 (38%) in the UC group versus 2 of 59 (3%) in the
controls (p,0.0001). There was also a negative association
between the identification of gastric Helicobacter species in UC (2
of 77) versus controls (9 of 59, p=0.007) (Table 4). There was no
correlation between the age, gender or extent of disease.
The effect of bowel preparation on Helicobacteraceae PCR
positivity was also considered. Of the 77 UC subjects, 32 had
full bowel preparation prior to colonoscopy along with all 59
control subjects. Helicobacteraceae PCR positivity in subjects with
bowel preparation was significantly higher in UC than controls [20
of 32 (63%) versus 11 of 59 (19%), (Pearson Chi squared test
p,0.0001)]. There was also a significant difference in Helicobacter-
aceae PCR positivity within the UC cohort based on bowel
preparation 20 of 32 (63% full bowel preparation), 1 of 5 (20%
phosphate enema preparation) vs 11 of 40 (28% no bowel
preparation), Pearson Chi squared test p=0.007). There was also
no statistically significant association with antibiotic usage.
Table 3. Archival Study FISH results.
Gender
Montreal Extent
of Disease Median Age
Eub 338
+ve (%)
HFam
+ve (%)
HP
+ve (%)
NpH
+ve (%)
UC Male 1 29 8 (100) 3 (38) 0 (0) 3 (38)
2 45 8 (100) 6 (75) 1 (13) 5 (63)
3 40 9 (100) 6 (67) 1 (11) 5 (56)
Total 32 25 (100) 15 (60) 2 (8) 13 (52)
Female 1 37 5 (100) 3 (60) 0 (0) 3 (60)
2 49 13 (100) 4 (31) 0 (0) 4 (31)
3 39 14 (100) 7 (50) 1 (7) 6 (43)
Total 42 32 (100) 14 (44) 1 (3) 13 (41)
Combined Total 40 57 (100) 29 (51) 3 (5)* 26 (46) **
Control Male 39 17 (100) 10 (59) 6 (35) 4 (24)
Female 47 32 (100) 16 (50) 7 (22) 9 (28)
Combined Total 42 49 (100) 26 (53) 13 (27)* 13 (27)**
*p=0.002 (Pearson Chi Squared 2 tailed test).
**p=0.04 (Pearson Chi Squared 2 tailed test).
doi:10.1371/journal.pone.0017184.t003
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available for both FISH and PCR based analyses. All samples
analysed by FISH were Eub338 positive indicating the presence of
bacteria. 62 of 77 (81%) UC were Helicobacteraceae positive whilst 1
was also H. pylori positive. In the 32 controls, 12 (38%) were
Helicobacteraceae positive whilst 2 were also H. pylori positive
(Table 6). The Helicobacteraceae positivity was significantly higher
in the UC cohort (p,0.0001) but no negative association with
Helicobacter pylori as seen in the archival FISH and prospective PCR
studies. As in the other studies there was no correlation between
the age, gender or extent of disease. Correlation between PCR and
FISH results for these 109 subjects were examined which
demonstrated concordance in 74 (68%) of subjects. The majority
of discordant results were attributable to a higher positivity rate for
Helicobacteraceae with FISH than PCR (Table 7).
Discussion
During the development of our combined molecular approach,
both the PCR and FISH techniques were highly sensitive and
specific (100% each) when interrogating gastric biopsies with
known H. pylori status. A further validation cohort utilising
Table 4. Prospective Study PCR results
Gender
Montreal Extent
of Disease Median Age
Universal Bacteria
+ve (%) HFam +ve (%)
Gastric
Species (%) EHH species (%)
UC Male 1 53 2 (100) 1 (50) 0 (0) 1 (50)
2 44 21 (100) 10 (48) 1 (5) 9 (43)
3 53 12 (100) 7 (58) 0 (0) 7 (58)
Total 45 35 (100) 18 (51) 1 (3) 17 (49)
Female 1 52 8 (100) 2 (25) 1 (13) 1 (13)
2 42 27 (100) 9 (33) 0 (0) 9 (33)
3 28 7 (100) 3 (43) 0 (0) 3 (43)
Total 41 42 (100) 14 (33) 1 (2) 13 (31)
Combined Total 42 77 (100) 32 (42)* 2 (3)** 30 (39)***
Control Male 61 35 (100) 6 (17) 4 (11) 2 (6)
Female 64 24 (100) 5 (21) 5 (21) 0 (0)
Combined Total 63 59 (100) 11 (19)* 9 (15)** 2 (3)***
*p=0.004 (Pearson Chi Squared 2 tailed test).
**p=0.007 (Pearson Chi Squared 2 tailed test).
***p,0.0001 (Pearson Chi Squared 2 tailed test).
doi:10.1371/journal.pone.0017184.t004
Table 5. Helicobacteraceae species identified by sequencing.
Helicobacteraceae Species Identified Number of Subjects Combination of Species identified in
UC Control
Single species identified
Helicobacter cinaedi 10
Helicobacter canadensis 10
Helicobacter cholecystus 90
Helicobacter hepaticus 51
Helicobacter mustelae 04
Helicobacter pullorum 51
Helicobacter pylori 25
Wolinella succinogenes 10
Two species co-existing within Subject
Helicobacter brantae
Helicobacter pullorum
10
Helicobacter cholecystus
Helicobacter bilis
10
Helicobacter cholecystus
Helicobacter canadensis
10
Helicobacter cholecystus
Helicobacter hepaticus
30
doi:10.1371/journal.pone.0017184.t005
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ity. However spiking experiments on this cohort indicate that
organisms would have been identified had they been present.
These findings suggest that Helicobacteraceae are not a prominent
causative agent in infectious diarrhoea in our setting although
they have been isolated from diarrhoeal samples by other
investigators [23–33]. Part of the rationale behind our developing
a combined approach to identify Helicobacteraceae, rather than one
based solely on either PCR or FISH, was that the combination of
techniques allows visualisation of organisms in-situ and species-
level identification from sequencing. PCR-only studies can be
criticised based on the possibility that contaminant environmental
DNA could bias results. In the gastrointestinal tract for instance,
DNA could be transited to the colon in the faecal stream from
foodstuffs. FISH addresses these concerns by allowing direct
visualisation and localisation of organisms to the colonic mucosa.
FISH-only studies however are limited by the constraints of
designing species-specific probes and therefore they lack species-
level sensitivity at times. By utilising both approaches Helicobacter-
aceae species present could be visualised and also identified. Based
on the strength of these validation studies, we considered that this
combined methodology was suitable for investigating Helicobacter-
aceae prevalence in UC colonic biopsies. A combined FISH/PCR
approach has also been utilised to examine Helicobacteraceae
prevalence in a small cohort of children with IBD (n=12)
(Crohn’s disease n=11), irritable bowel syndrome (IBS; n=5)
and controls (n=4) [9]. This small study identified a strikingly
high prevalence in both IBD (11/12) and IBS (5/5) versus
controls (1/4). Through sequence analysis of DGGE bands
several Helicobacteraceae were identified including Helicobacter
ganmani, Wolinella succinogenes, H. hepaticus and H. pylori.T w o
further bands were identified as Helicobacter although equal
sequence similarity was attributed to multiple species.
The results of our study show that rates of Helicobacteraceae
positivity are significantly higher in the colonic tissue of UC
patients than in controls. When sequencing data is analysed and
species identities attributed, in control patients, the species
identified are almost exclusively gastric (namely H. pylori and H.
mustelae (99–100% sequence similarity); comprising 9 of 11). This
finding is in stark contrast to the Helicobacter sequences from the
UC cohort where 32 patients had Helicobacteraceae species
identified, although only 2 of these were attributed to H. pylori
and curiously, H. mustelae was absent. Our study was not designed
to obtain gastric Helicobacter species. As such it was not possible to
confirm or refute the notion that Helicobacter species detected in the
colon are truly colonising the mucus or merely transiting from the
stomach. For the former, Helicobacter grown from both sites
(stomach and colon) would be necessary in order to undertake a
detailed strain comparison, which was not feasible within this
study. As indicated in the results section there was also a
statistically significant difference in age between the UC and
control groups. The difference in age between the two groups is a
result of the control group predominantly being recruited from a
colorectal cancer screening programme whose lower age limit is 50
years.
Interestingly, bowel preparation appeared to increase the
detection of Helicobacter species. It might be anticipated that the
wash-out effect of bowel preparation might reduce the positivity.
Table 6. Prospective Study FISH results.
Gender
Montreal Extent
of Disease Median Age Eub 338 +ve (%) HFam +ve (%) HP +ve (%) NpH +ve (%)
UC Male 1 53 2 (100) 2 (100) 0 2 (100)
2 44 21 (100) 16 (76.2) 1 (4.8) 15 (71.4)
3 53 12 (100) 12 (100) 0 12 (100)
Total 45 35 (100) 30 (85.7) 1 29 (64.4)
Female 1 53 8 (100) 8 (100) 0 8 (100)
2 42 27 (100) 20 (74.1) 0 20 (74.1)
3 28 7 (100) 4 (57.4) 0 4 (57.4)
Total 41 42 (100) 32 (76.2) 0 32 (76.2)
Combined Total 42 77 (100) 62 (85.7)* 1 (1.3) 61 (79.2) **
Control Male 64 15 (100) 5 (33.3) 0 5 (33.3)
Female 64 17 (100) 7 (41.2) 2 (11.7) 5 (29.4)
Combined Total 64 32 (100) 12 (37.5)* 2 (6.3) 10 (31.1)**
*p,0.0001 (Pearson Chi Squared 2 tailed test).
**p,0.0001 (Pearson Chi Squared 2 tailed test).
doi:10.1371/journal.pone.0017184.t006
Table 7. Correlation of PCR and FISH results.
FISH Helicobacter negative (%) FISH Helicobacteraceae positive (%) FISH H. pylori positive (%)
PCR Helicobacter Negative 35 (32%) 35 (32%) 0
PCR Helicobacteraceae positive 0 39 (36%) 2 (2%)
PCR H. pylori positive 0 0 1 (1)
doi:10.1371/journal.pone.0017184.t007
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confounding factor or could be a surrogate disease severity
marker. This was due to it being a clinical decision whether
subjects received bowel preparation or not. As no bowel
preparation was given when there was the clinical impression of
severe disease. This suggests that Helicobacteraceae positivity is
associated with less severe disease. However no association
between Helicobacteraceae positivity and the Montreal classification
of disease extent and severity was observed.
Six of the UC patients appear to have multiple Helicobacter
species present within their colonic tissue. Two of the six had
different Helicobacter sequences identified from the same biopsy
whereas the other four had single Helicobacter species identified
from biopsies taken from different regions of the colon. Mixed
species were not identified in the control cohort although it should
be acknowledged that only single colonic sites were investigated by
biopsy. Nevertheless our findings suggest that more than one
enterohepatic Helicobacter species can be present in the same
human host although this does not appear to be the case for gastric
species.
It should be noted that allocation of species should not rely
solely on 16S rRNA sequencing as comparison of these
sequences can be misleading and does not always provide
conclusive evidence for species level identification. Helicobacter
species identity cannot be firmly established by 16S sequencing
and the 400 bp product of the nested PCR further compounded
this by only allowing sequencing over this short segment.
However there is confidence tha tt h es e q u e n c eb e l o n g e dt ot h e
genus Helicobacter based on the sequenced product. For example,
although our nested PCR technique amplified a hyper-variable
region of the 16S rRNA Helicobacter genome which equated to
an estimated average evolutionary diversity of 14 base pairs
within the 9 species identified [34], it is not possible to be
certain of the Helicobacter species without additional genotypic or
phenotypic characterisation [35]. There is always the possibility
that mixed Helicobacter organisms were present that had identical
sequences over the 400 bp 16S rDNA region analysed. It is
possible that alternative identification approaches including
denaturing gradient gel electrophoresis (DGGE) could have
been used to address this potential issue. Where sequence
analysis indicated that mixed species were present, the
additional cloning and sequencing approach was undertaken
which demonstrated the presence of multiple Helicobacter
sequences within a few samples.
The use of nested PCR is known to increase the sensitivity of the
PCR test; however it is also known that without strict use of
appropriate control strategies including sequencing of positive
results, it can lead to false positives. In the current study, all
positive nested PCR findings were sequenced in order to eliminate
the query of false positives due to nested PCR. Extensive attempts
were made to isolate Helicobacter species from the prospective
cohort, however this was not successful. Helicobacter species are
notoriously fastidious and although novel Helicobacter species have
been isolated from human faeces, to date none have been isolated
from colonic tissue. Examining both FISH and PCR analyses on a
large number of samples (n=109) revealed a correlation rate of
,68%. In the majority of cases, discordant results showed that
FISH was more likely to yield a positive result than PCR. This was
not seen in our gastric validation cohort. The most likely
explanation is that the number of H. pylori strains present in
infected gastric tissue is higher than the corresponding number of
Helicobacter species in the colon. These results suggest that the
FISH technique is more sensitive but lacks the specificity to
identify the Helicobacteraceae species. Regardless of these technical
issues, both techniques demonstrate a statistically significant
correlation between the presence of Helicobacteraceae species,
particularly the enterohepatic Helicobacter species and the UC
cohort.
The PCR methodology that we developed used a nested PCR
approach for Helicobacteraceae but a single PCR was used for H.
pylori. It is likely that a nested PCR for H. pylori would have been
more sensitive in the colonic samples and would have increased
the detection rate. This is a plausible explanation for at least 3 of
the four samples which were shown by sequence analysis of the
Helicobacteraceae PCR product to contain H. pylori despite H. pylori
PCR results being negative. Nevertheless, in order to identify every
Helicobacter that was detected, we chose to sequence every positive
PCR reaction including those that were H. pylori positive in order
to determine whether multiple species were present.
Attributing causation to putative pathogens has always been a
difficult endeavour with the gold standard remaining fulfilment of
Koch’s postulates [36]. In an era of molecular biology and an
increasing awareness of the ‘‘unculturable’’ microbiota of the
human colon however, these postulates are perhaps outdated.
Swidsinski and colleagues recently proposed alternative postulates
for a modern era [37]:
N There must be a clear link between a pathogen and a disease,
N The pathogenic organism should be identified and charac-
terised (by traditional culture and phenotyping or by ‘‘reliable’’
modern methods such as PCR, DNA sequencing and FISH),
N There should be positive evidence of the chain of infection (this
can be from individual transfections or from epidemiological
observation)
N Knowledge of a specific pathogen should assist the develop-
ment of new diagnostic methods and treatment
We would add that host factors, in particular genetic or
immunological susceptibility should be considered, particularly in
the context of IBD. We believe that our data adds considerable
weight to fulfilling Swidsinski’s second postulate and that the first
has already been firmly established in animal models. Further
work is required to address the third postulate which would clearly
be aided by successful culture of these organisms from the colonic
tissue of UC patients.
Finally, the presence of H. mustelae in the colonic tissue of
controls but not UC patients warrants further consideration. Since
H. mustelae is a gastric organism (previously only identified in ferrets
[38]), it would be interesting to see if this species is co-colonising
the human stomach and colon, the colon alone or simply being
transited to the colon from the stomach. H. mustelae has a similar
morphology to H. pylori and is also a urease positive organism so it
could easily be mistaken with current clinical testing (CLO test) for
H. pylori in human gastric disease. It may be that H. mustelae
represents a less pathogenic organism in the human host which
nonetheless confers the IBD protective benefits of H. pylori [39]. In
terms of the extra-gastric Helicobacters our findings clearly
demonstrate compelling molecular evidence for their presence in
the human colon. Their presence in the human host is not well
established compared to animal models however; there is no
reason to suggest that they do not reside in the human intestinal
tract. Clearly these hypotheses require further exploration.
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